CHRONIC HEPATITIS B VIRUS INFECTION
Clinical trials for CHRONIC HEPATITIS B VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B VIRUS INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug IB-001 enters first human tests for chronic hepatitis b
Disease control Recruiting nowThis early-stage study tests a new drug called IB-001 for chronic hepatitis B. It will first check safety in up to 60 healthy volunteers, then test multiple doses in about 30 people with chronic hepatitis B. The main goal is to see if the drug is safe and how the body handles it.
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE1 • Sponsor: IntegerBio • Aim: Disease control
Last updated Jun 22, 2026 12:06 UTC
-
New hepatitis b drug enters first human tests
Disease control Recruiting nowThis early-stage trial is testing a new drug called GIGA-2339 in 48 people with chronic hepatitis B. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo by IV infusion, and researchers will monitor for sid…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE1 • Sponsor: GigaGen, Inc. • Aim: Disease control
Last updated Jun 22, 2026 12:01 UTC
-
New hope for hepatitis b: 48-Week drug trial launches
Disease control Recruiting nowThis study tests a new drug called HH-006 in 45 adults with chronic hepatitis B. Participants will receive the drug for 48 weeks and be monitored for changes in virus levels and liver function. The goal is to see if the drug can safely control the infection and reduce the amount …
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC